IGF-1 overexpression was suggested in the past as a modulator of SMA severity in mice, the finding that insulin resistance is associated with IGF-1 levels raised concerns that insulin resistance may attenuate the IGF-1 myotrophic effect [94]. This evidence concerns the gene IGF1 and Insulin resistance.